Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
esmo
May 18, 2024, 02:26 |
Blog
Stephanie Graff: Absolute highlight sharing the stage with Drs. Wolfgang Janni and Carlos Barrios
Quoting Stephanie Graff’s post: . “As I (finally) board to leave ESMO Breast 24, I want to say…
May 17, 2024, 16:02 |
Blog
Marta Perachino: Check out our systematic review and metanalysis of ADCs vs TPC for mBC
Marta Perachino, Research fellow at Vall d’Hebron Institute of Oncology, shared a post on X: "For…
May 17, 2024, 15:13 |
Societies
Elisabetta Munzone: TIP poster PREcoopERA trial for premenopausal women with early breast cancer
Elisabetta Munzone, Medical oncologist and Breast Cancer specialist at the European Institute of Oncology, shared…
May 17, 2024, 11:25 |
Insight
Stefan Michiels: Discussing important clinical trial design challenges in breast cancer!
Stefan Michiels, Head Oncostat Team at INSERM, shared a post by Marleen Kok, Associate Professor…
May 15, 2024, 13:25 |
Blog
Martin Guscott: Neuro-oncology Research and Care Network
Ruzanna Papyan shared a post by Martin Guscott, Vice President of Medical Affairs at Resonance, on…
May 15, 2024, 04:12 |
Blog
Tanja Obradovic: News about effectiveness of PD-1 inhibitors in endometrial cancer continues to paint complex picture
Tanja Obradovic shared on LinkedIn: ''News about effectiveness of PD-1 inhibitors in endometrial cancer continues…
May 13, 2024, 14:53 |
Blog
Ruzanna Papyan: The life-saving potential of anti-GD2 therapy in treating high-risk neuroblastoma
Ruzanna Papyan shared the following on LinkedIn: ''Week 2 of the Global Access To AntiGD2…
May 12, 2024, 17:41 |
Insight
Marco Donia: Circadian rhythm, tumor infiltration of CD8+ T cells, and cancer immunotherapy
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: “Circadian…
May 12, 2024, 12:41 |
Insight
Salvador Santiesteban: Oligometastatic breast cancer and oligoprogression
Salvador Santiesteban, Medical oncologist from the National Institute of Medical Sciences and Nutrition, shared on…
May 12, 2024, 12:13 |
Insight
Herbert Loong: 6 versus 3 years of adjuvant imatinib in high risk GISTs by Jean-Yves Blay et al.
Herbert Loong shared on LinkedIn: “Congrats Jean-Yves Blay and colleagues of French Sarcoma Group for completing…
56
57
58
59
60
All:
748
Posts:
571 - 580
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube